|Avoid NSAIDs in third trimester [87]|Strong| |
|Use nonselective rather than COX-2â€“specific NSAIDs [88]|Conditional| |
|Discontinue MTX, MMF, thalidomide, CYC prior to conception [102, 120, 140, 134]|Strong| |
|Use CYC for life-threatening disease only in second and third trimester [136]|Conditional| |
|Discontinue leflunomide 24 months prior to conception or check serum metabolite levels and treat with cholestyramine washout [109, 110]|Strong| |
|Continue HCQ, sulfasalazine, AZA, colchicine [91, 95, 116, 98]|Strong| |
|Continue cyclosporine and tacrolimus [127, 131]|Conditional| |
|Continue certolizumab [156]|Strong| |
|Continue infliximab, etanercept, adalimumab, golimumab [144, 147, 150, 153]|Conditional| |
|Stop when pregnancy confirmed: rituximab, belimumab, anakinra, abatacept, tocilizumab, secukinumab, ustekinumab [164, 169, 160, 173, 177, 181, 185]|Conditional| |
|Use rituximab for organ-or life-threatening disease during pregnancy [165]|Conditional| |